Dexcom CEO Talks Stelo Launch, Broader Plans, And GLP1 Misconceptions

Medtech Insight spoke to Dexcom CEO Kevin Sayer, ahead of this year’s Advanced Technologies & Treatments for Diabetes conference, to get an update on the company’s recent news, future strategy and where he feels his company’s market is headed.